Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT00959036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Seamless, Phase 1/2, Multiple Ascending Dose, Proof Of Concept Study Of ATN-103 Administered To Subjects With Active Rheumatoid Arthritis On A Background Of Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of ATN-103 when administered to subjects with active rheumatoid arthritis compared with placebo. All subjects must be on a stable dose and route of methotrexate.
Study identification
- NCT ID
- NCT00959036
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- Jan 30, 2013
2009 – 2011
United States locations
- U.S. sites
- 37
- U.S. states
- 22
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Birmingham | Alabama | 35209 | — |
| Investigational Site | Huntsville | Alabama | 35801 | — |
| Investigational Site | Peoria | Arizona | 85381 | — |
| Investigational Site | Scottsdale | Arizona | 85258 | — |
| Investigational Site | Riverside | California | 92501 | — |
| Investigational Site | Upland | California | 91786 | — |
| Investigational Site | Bridgeport | Connecticut | 06606 | — |
| Investigational Site | Newark | Delaware | 19713 | — |
| Investigational Site | Lake Mary | Florida | 32746 | — |
| Investigational Site | Ocala | Florida | 34474 | — |
| Investigational Site | Orlando | Florida | 32804 | — |
| Investigational Site | Port Orange | Florida | 32127 | — |
| Investigational Site | Vero Beach | Florida | 32960 | — |
| Investigational Site | Coeur d'Alene | Idaho | 83814 | — |
| Investigational Site | Frederick | Maryland | 21702 | — |
| Investigational Site | West Yarmouth | Massachusetts | 12672 | — |
| Investigational Site | Lansing | Michigan | 48910 | — |
| Investigational Site | Freehold | New Jersey | 07728 | — |
| Investigational Site | Albuquerque | New Mexico | 87108 | — |
| Investigational Site | Mineola | New York | 11501 | — |
| Investigational Site | Charlotte | North Carolina | 28210 | — |
| Investigational Site | Hickory | North Carolina | 28601 | — |
| Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Investigational Site | Winston-Salem | North Carolina | 27157 | — |
| Investigational Site | Columbus | Ohio | 43213 | — |
| Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Investigational Site | Oklahoma City | Oklahoma | 73139 | — |
| Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Investigational Site | Lake Oswego | Oregon | 97035 | — |
| Investigational Site | Allentown | Pennsylvania | 18103 | — |
| Investigational Site | Columbia | South Carolina | 29204 | — |
| Investigational Site | Myrtle Beach | South Carolina | 29572 | — |
| Investigational Site | Nashville | Tennessee | 37205 | — |
| Investigational Site | Dallas | Texas | 75235 | — |
| Investigational Site | Houston | Texas | 77004 | — |
| Investigational Site | San Antonio | Texas | 78217 | — |
| Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00959036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 30, 2013 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00959036 live on ClinicalTrials.gov.